XORTX Therapeutics XRTX
NASDAQ XRTX
$1.69 -0.01 (-0.59%)
At close: Sep 30, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Other Operating Expenses (2020 - 2026)

Updated

XORTX Therapeutics' Other Operating Expenses was -$34,200 in the quarter ended Jun 30, 2026, compared with $100,882 a year earlier.

Analysis

XORTX Therapeutics (XRTX) Other Operating Expenses (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, XORTX Therapeutics' Other Operating Expenses was $444,791 through Jun 30, 2026, up 9.9% year-over-year; for the year ended Dec 31, 2025, it was $250,022, down 44.5% from the prior year.

  • Other Operating Expenses shows a five-year compound annual growth rate of 15.6% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Other Operating Expenses was $450,553 in the year ended Dec 31, 2024 (+18.2%), $381,154 in the year ended Dec 31, 2023 (-16.1%), $454,071 in the year ended Dec 31, 2022 (+100.6%) and $226,374 in the year ended Dec 31, 2021 (+86.5%).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Other Operating Expenses since the quarter ended Sep 30, 2021.
  • Compared with a year earlier, Other Operating Expenses was higher in three of the last seven quarters, with growth averaging 94.0%.
  • The best year-over-year quarter for Other Operating Expenses over five years was the quarter ended Dec 31, 2025 (growth of 412.4%); the worst was the quarter ended Sep 30, 2025 (a decline of 84.2%).
  • Per Business Quant data, XRTX's Other Operating Expenses in the three quarters before the quarter ended Jun 30, 2026 was $312,379 (quarter ended Mar 31, 2026), $135,710 (quarter ended Dec 31, 2025) and $30,902 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 XORTX Therapeutics 1.60 Mn -1.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -34,200.00
Mar 31, 2026 312,379.00
Dec 31, 2025 135,710.00
Sep 30, 2025 30,902.00
Jun 30, 2025 100,882.00
Mar 31, 2025 81,834.00
Dec 31, 2024 26,487.00
Sep 30, 2024 195,527.00
Jun 30, 2024 274,635.00
Mar 31, 2024 89,209.43
Dec 31, 2023 41,400.63
Sep 30, 2023 76,545.15
Jun 30, 2023 159,629.22
Mar 31, 2023 104,192.15
Dec 31, 2022 68,096.40
Sep 30, 2022 43,124.88
Jun 30, 2022 173,369.09
Mar 31, 2022 106,805.00
Dec 31, 2021 71,246.00
Sep 30, 2021 -253,896.39
API Access

XORTX Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=XRTX&period=max&api_key=YOUR_API_KEY